
1. Pathogens. 2019 Apr 7;8(2). pii: E47. doi: 10.3390/pathogens8020047.

ApiAP2 Transcription Factors in Apicomplexan Parasites.

Jeninga MD(1), Quinn JE(2), Petter M(3)(4).

Author information: 
(1)Mikrobiologisches Institut-Klinische Mikrobiologie, Immunologie und Hygiene,
Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU)
Erlangen-Nürnberg, 91054 Erlangen, Germany. myriam.jeninga@uk-erlangen.de.
(2)Mikrobiologisches Institut-Klinische Mikrobiologie, Immunologie und Hygiene,
Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU)
Erlangen-Nürnberg, 91054 Erlangen, Germany. jennifer.quinn@uk-erlangen.de.
(3)Mikrobiologisches Institut-Klinische Mikrobiologie, Immunologie und Hygiene,
Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU)
Erlangen-Nürnberg, 91054 Erlangen, Germany. michaela.petter@uk-erlangen.de.
(4)Department of Medicine, The University of Melbourne, Melbourne, VIC 3010,
Australia. michaela.petter@uk-erlangen.de.

Apicomplexan parasites are protozoan organisms that are characterised by complex 
life cycles and they include medically important species, such as the malaria
parasite Plasmodium and the causative agents of toxoplasmosis (Toxoplasma gondii)
and cryptosporidiosis (Cryptosporidium spp.). Apicomplexan parasites can infect
one or more hosts, in which they differentiate into several morphologically and
metabolically distinct life cycle stages. These developmental transitions rely on
changes in gene expression. In the last few years, the important roles of
different members of the ApiAP2 transcription factor family in regulating life
cycle transitions and other aspects of parasite biology have become apparent.
Here, we review recent progress in our understanding of the different members of 
the ApiAP2 transcription factor family in apicomplexan parasites.

DOI: 10.3390/pathogens8020047 
PMCID: PMC6631176
PMID: 30959972 

